基于Cereblon的PROTACs的合成,生物评估和临床试验
André T S Vicente1,2,3, Sara P S P Moura1,2,3, Jorge A R Salvador4,5,6
1Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
Communications chemistry
|July 29, 2025
概括
针对蛋白质溶解的嵌合体 (PROTACs) 利用细胞的机械来降解蛋白质. 本综述批判性地分析了基于cereblon的PROTAC,强调了它们的治疗潜力和未来方向.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 针对蛋白质溶解的奇默体 (PROTACs) 是一种新的治疗方法.
- PROTACs通过E3结合酶招募诱导向蛋白质降解.
- 基于Cereblon (CRBN) 的PROTAC是最受研究的类别.
研究的目的:
- 提供基于cereblon的PROTACs的全面分析.
- 涵盖最近的进展,挑战和未来的前景.
- 为了指导未来的研究在PROTAC药物发现.
主要方法:
- 关于PROTAC设计和合成的最新进展的文献综述.
- 对临床前和临床评估数据的分析.
- 药物发现和开发见解的整合.
主要成果:
- 通过劫持细胞降解途径,PROTACs提供了一种独特的治疗策略.
- 基于Cereblon的PROTAC显示出治疗各种疾病的前景,包括癌症和神经系统疾病.
- 目前,一些基于大脑的PROTAC正在临床试验中.
结论:
- 基于cereblon的PROTACs是一个快速发展的领域,具有显著的治疗潜力.
- 需要进一步的研究来应对设计,合成和临床评估方面的挑战.
- 在未来的药物开发中,PROTACs将成为一种重要的模式.
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K


